cro.directory
← Home
CuriRx, Inc. logo

CuriRx, Inc.

Contract formulation, bioprocessing, and analytical development for pharmaceutical innovators.

CuriRx provides formulation development, advanced bioprocessing, and analytical services to pharmaceutical companies. Capabilities include prefilled syringes, lyophilization, cell line development, upstream/downstream process development, and CMC analytical support via the CuriLytics® platform. Headquartered in Wilmington, United States.

Services

Modalities

About this organization

Overview

CuriRx is a contract research and development organization (CRDMO) serving pharmaceutical companies of all sizes. The company specializes in formulation development, advanced bioprocessing, and comprehensive analytical services.

Core Service Areas

Formulation Development

  • Prefilled syringe formulation and manufacturing
  • Formulation studies and optimization
  • Lyophilization services
  • Nanotechnology formulation support

Advanced Bioprocessing

  • Cell line and strain development
  • Upstream process development
  • Downstream process development

Analytical Services

  • CuriLytics® platform for CMC analytical support
  • High-resolution mass spectrometry
  • Analytical testing for biopharmaceuticals and biologics
  • Small molecule pharmaceutical analysis
  • Gene therapy analytical support
  • Quality testing, qualification, and validation
  • Stability studies

Differentiation

CuriRx emphasizes agility, quality improvement, and partnership-oriented service delivery. The company has earned recognition from clients including Tourmaline, Uvax Bio, Incyte, and Fidelity BioPharma for formulation expertise, project execution speed, and high-quality deliverables on injectable and 505(b)(2) projects.

Locations

  • Headquarters

    Wilmington · MA · USA

Similar profiles by shared services, phases, and indications.

Submit a verified review for this organization.

Markdown mirror: /companies/curirx.md